Atorvastatin price trends
Pro Research Analysisby 
Searched over 200M research papers
Atorvastatin Price Trends Across Countries
International Price Reductions After Generic Entry
After the introduction of generic atorvastatin, significant price reductions were observed in multiple countries. In Australia, New Zealand, the Republic of Korea, and Singapore, prices dropped by 46–80% within four years of generic entry. New Zealand, which already had the lowest prices due to its tendering system and use of preferred medicines, saw little change, while Singapore experienced the largest immediate decrease (46% in the first year). Despite these reductions, notable price differences between countries persisted, with New Zealand maintaining the lowest prices both before and after generic entry. Australia’s combination of mandatory price cuts and price-disclosure policies achieved similar reductions to tendering systems, while Korea’s reliance on mandatory price cuts alone resulted in the smallest relative reduction after four years149.
Atorvastatin Pricing in Europe
In Greece, regulatory policies set generic atorvastatin prices at 65% of the reference off-patent price, with further reductions based on comparisons with the lowest prices in other EU countries. As a result, the average ex-factory price for generic atorvastatin in Greece was up to 52.73% lower than in some other EU countries. Additional rebates and clawbacks further reduced prices by about 30%. However, despite these low prices, generic penetration remained below targets, indicating that pricing alone may not drive higher usage without additional incentives for prescribers and patients.
In Belgium, the entry of generic atorvastatin led to projections of a 50–70% price reduction, resulting in substantial annual savings for healthcare payers. Atorvastatin was expected to become the dominant statin, with market share by expenditure reaching 47–66% by 2015. These price reductions improved the cost-effectiveness of statin therapy overall68.
Atorvastatin Price Trends in India
India’s market for atorvastatin is characterized by significant price variation among brands. Studies found that the costliest brand of atorvastatin 40 mg could be more than four times the price of the cheapest brand, with percentage variations reaching up to 900% for some dosages. This wide disparity places a financial burden on patients and highlights the importance of prescribers considering cost when choosing brands37.
Price regulation through the Drug Price Control Order (DPCO) in 2013 led to a modest but statistically significant increase in atorvastatin’s market share among statins, suggesting that price controls can improve access and usage, though price variation among brands remains high57.
Atorvastatin Pricing in the United States
In the US, the cost-effectiveness of atorvastatin changed over its product life cycle. The incremental cost-effectiveness ratio (ICER) of atorvastatin compared to simvastatin increased after generic simvastatin became available, but decreased again after generic atorvastatin entered the market. Over the full period modeled (1997–2030), atorvastatin remained cost-effective, with its value to payers increasing as prices fell post-generic entry.
Conclusion
Atorvastatin prices have generally declined significantly following the introduction of generics, with reductions of 46–80% observed in many countries. The extent of price reduction depends on national policies, with tendering systems and combined price-disclosure mechanisms achieving the greatest savings. However, substantial price variation persists between countries and even among brands within countries like India. While lower prices improve cost-effectiveness and access, additional measures may be needed to increase generic uptake and ensure affordability for all patients1234+6 MORE.
Sources and full results
Most relevant research papers on this topic